Prostaglandin E1
From DrugPedia: A Wikipedia for Drug discovery
|
Prostaglandin E1
| |
Systematic (IUPAC) name | |
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C20H34O5 |
Mol. mass | 354.48 |
SMILES | & |
Synonyms | Sugiran |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
prostaglandin oligomeric derivative; RN given refers to cpd with unknown MF; inhibits several lipolytic and proteolytic enzymes
[edit] General Properties
*Molecular Weight
354.48
*Molecular Formula
C20H34O5
*IUPAC NAME
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
*Canonical Smiles
CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O
*Isomeric Smiles
CCCCC[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O
[edit] PhysioChemical Properties
*Melting Point
*LogP
*Water Solubility